• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3个月的F-18氟代脱氧葡萄糖正电子发射断层显像/X线计算机体层成像(F-18 FDG PET/CT)监测在手术切除的口腔鳞状细胞癌中的应用价值

Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.

作者信息

Marquardt Michael, Anderson Carryn, Ginader Timothy, Parkhurst Jessica, Pagedar Nitin, Bayon Rodrigo, Clamon Gerald, Hoover Andrew, Buatti John

机构信息

1 Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

2 Department of Biostatistics, University of Iowa College of Public Health, Iowa City, Iowa, USA.

出版信息

Ann Otol Rhinol Laryngol. 2018 Mar;127(3):185-191. doi: 10.1177/0003489417751474. Epub 2018 Jan 9.

DOI:10.1177/0003489417751474
PMID:29313371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6445268/
Abstract

OBJECTIVES

To evaluate the performance of surveillance F-18 fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) 1 year after imaging in oral squamous cell carcinoma (OSCC) patients treated with definitive surgery and adjuvant (chemo)radiotherapy (RT).

METHODS AND MATERIALS

Surveillance PET/CT accuracy was retrospectively evaluated in OSCC patients receiving surgical resection and (chemo)RT. Pathologic risk factors were assessed for influence on accuracy of the post-RT PET/CT.

RESULTS

Fifty-four patients with median follow-up of 3.8 years met inclusion criteria. A PET/CT obtained a median of 3.4 months after RT revealed 11 (20.4%) instances of true disease recurrence: 4 locoregional alone, 6 distant alone, and 1 patient with locoregional and distant disease. Locoregional detection sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 55.6%, 75.0%, 33.3%, and 88.2%, respectively. For distant recurrence, the respective values were 100%, 95.2%, 77.8%, and 100%. Absence of bone invasion, absence of pT4 disease, and disease within the tongue were independently associated with higher sensitivity ( P = .048). Perineural invasion was associated with increased specificity ( P = .027), and tumor location in the tongue was associated with a higher PPV ( P = .007) on surveillance PET/CT.

CONCLUSIONS

Post-RT PET/CT accuracy information for surgically managed OSCC patients demonstrates significant associations with pathologic factors.

摘要

目的

评估接受根治性手术及辅助(化疗)放疗(RT)的口腔鳞状细胞癌(OSCC)患者在成像后1年进行的监测F-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(PET/CT)的性能。

方法和材料

对接受手术切除及(化疗)放疗的OSCC患者的监测PET/CT准确性进行回顾性评估。评估病理危险因素对放疗后PET/CT准确性的影响。

结果

54例中位随访时间为3.8年的患者符合纳入标准。放疗后中位3.4个月进行的PET/CT显示11例(20.4%)真正的疾病复发:4例仅为局部区域复发,6例仅为远处复发,1例患者同时有局部区域和远处疾病。局部区域检测的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为55.6%、75.0%、33.3%和88.2%。对于远处复发,相应的值分别为100%、95.2%、77.8%和100%。无骨侵犯、无pT4期疾病以及病变位于舌部与更高的敏感性独立相关(P = .048)。神经周围侵犯与特异性增加相关(P = .027),舌部的肿瘤位置与监测PET/CT上更高的PPV相关(P = .007)。

结论

手术治疗的OSCC患者放疗后PET/CT准确性信息与病理因素存在显著关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f94d/6445268/bf6650948df8/nihms-1005831-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f94d/6445268/bf6650948df8/nihms-1005831-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f94d/6445268/bf6650948df8/nihms-1005831-f0001.jpg

相似文献

1
Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.3个月的F-18氟代脱氧葡萄糖正电子发射断层显像/X线计算机体层成像(F-18 FDG PET/CT)监测在手术切除的口腔鳞状细胞癌中的应用价值
Ann Otol Rhinol Laryngol. 2018 Mar;127(3):185-191. doi: 10.1177/0003489417751474. Epub 2018 Jan 9.
2
Use of Diffusion-Weighted Imaging and F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.弥散加权成像和 F-氟代脱氧葡萄糖正电子发射断层扫描与计算机断层扫描联合应用于头颈部鳞状细胞癌放化疗反应评估。
Clin Oncol (R Coll Radiol). 2018 Dec;30(12):780-792. doi: 10.1016/j.clon.2018.09.007. Epub 2018 Oct 11.
3
Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.定量扩散加权成像和 18-F-FDG-PET 在头颈部鳞状细胞癌(放化疗)治疗中的预测价值。
Eur J Radiol. 2019 Apr;113:39-50. doi: 10.1016/j.ejrad.2019.01.031. Epub 2019 Feb 4.
4
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.氟代脱氧葡萄糖正电子发射断层显像/增强CT作为头颈部鳞状细胞癌的治疗后评估工具:与氟代脱氧葡萄糖正电子发射断层显像/非增强CT及增强CT的比较
Eur Radiol. 2016 Apr;26(4):1018-30. doi: 10.1007/s00330-015-3902-1. Epub 2015 Jul 19.
5
Comparison of diffusion-weighted MR imaging and F Fluorodeoxyglucose PET/CT in detection of residual or recurrent tumors and delineation of their local spread after (chemo) radiotherapy for head and neck squamous cell carcinoma.比较弥散加权磁共振成像和 F 氟脱氧葡萄糖 PET/CT 在头颈部鳞状细胞癌放化疗后检测残留或复发性肿瘤及局部扩散中的应用。
Eur J Radiol. 2020 Sep;130:109157. doi: 10.1016/j.ejrad.2020.109157. Epub 2020 Jun 30.
6
Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)对头颈部癌原发淋巴结靶区定义的影响
Acta Oncol. 2016 Sep-Oct;55(9-10):1099-1106. doi: 10.1080/0284186X.2016.1182643. Epub 2016 May 24.
7
Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.头颈部鳞状细胞癌放化疗结束3个月后,(18)氟脱氧葡萄糖正电子发射断层显像-计算机断层扫描(FDG PET-CT)用于疗效评估的准确性:至少2年的随访
Head Neck. 2016 Apr;38 Suppl 1:E1271-6. doi: 10.1002/hed.24204. Epub 2015 Aug 28.
8
Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.头颈部鳞状细胞癌放化疗前正电子发射断层扫描/计算机断层扫描上的氟脱氧葡萄糖热点与局部复发优势部位之间的相关性
Head Neck. 2017 Jun;39(6):1155-1165. doi: 10.1002/hed.24738. Epub 2017 Mar 6.
9
Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.术前对比增强CT与¹⁸F-FDG PET/CT评估及结外侵犯对头颈部鳞状细胞癌手术患者的预后价值
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1020-7. doi: 10.1245/s10434-015-4689-7. Epub 2015 Jun 30.
10
18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.18F-FDG PET/CT 检测复发性头颈部鳞状细胞癌患者的远处转移。
J Surg Oncol. 2012 Nov;106(6):708-12. doi: 10.1002/jso.23185. Epub 2012 Jun 4.

本文引用的文献

1
FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在口腔鳞状细胞癌的管理和评估结局中的应用。
AJR Am J Roentgenol. 2015 Aug;205(2):W150-61. doi: 10.2214/AJR.14.13830. Epub 2015 May 22.
2
The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction.(18)F-FDG-PET/CT成像在口腔癌患者手术重建后的价值。
Laryngoscope. 2015 Aug;125(8):1861-8. doi: 10.1002/lary.25326. Epub 2015 Apr 17.
3
Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.
头颈部鳞状细胞癌成像的当前肿瘤学概念与新兴技术
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012;11:Doc08. doi: 10.3205/cto000090. Epub 2012 Dec 20.
4
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis.治疗后 FDG PET 或 FDG PET/CT 成像在头颈部癌症中的诊断性能:系统评价和荟萃分析。
Eur J Nucl Med Mol Imaging. 2011 Nov;38(11):2083-95. doi: 10.1007/s00259-011-1893-y. Epub 2011 Aug 19.
5
Oral squamous cell carcinoma: clinicopathological features in patients with and without recurrence.口腔鳞状细胞癌:有复发和无复发患者的临床病理特征
ORL J Otorhinolaryngol Relat Spec. 2011;73(3):170-6. doi: 10.1159/000328340. Epub 2011 May 27.
6
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.评估 18F-FDG PET/CT 和 CT/MRI 与头颈部鳞状细胞癌挽救性手术患者的组织病理学相关性。
Ann Surg Oncol. 2011 Sep;18(9):2579-84. doi: 10.1245/s10434-011-1655-x. Epub 2011 Mar 16.
7
Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.放疗后 4-6 个月行体格检查与氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对比评估头颈部肿瘤残留。
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e825-32. doi: 10.1016/j.ijrobp.2010.11.072. Epub 2011 Feb 6.
8
Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation.高精准度根治性(放)化疗治疗头颈部鳞状细胞癌患者中,基于 FDG-PET/CT 的疗效评估的诊断性能。
Radiother Oncol. 2010 Nov;97(2):194-9. doi: 10.1016/j.radonc.2010.04.028. Epub 2010 Jun 2.
9
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.头颈部癌放疗后基于正电子发射断层扫描/计算机断层扫描的随访的诊断和预后效用。
Cancer. 2009 Oct 1;115(19):4586-94. doi: 10.1002/cncr.24493.
10
Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?对于临床随访中疾病呈阴性的患者,18F-FDG PET/CT能否提高头颈部鳞状细胞癌治疗后复发的检测率?
J Nucl Med. 2009 Jan;50(1):24-9. doi: 10.2967/jnumed.108.055806. Epub 2008 Dec 17.